Colorado Backs Experimental Drugs for Dying Patients

Monday, 19 May 2014 09:27 AM

By Drew MacKenzie

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
The growing pressure to allow experimental drugs to be used on dying patients has been given a vital boost in Colorado, where a so-called "right-to-try" bill became law over the weekend.

Although the measure is the first in the nation, lawmakers in several states are pushing similar legislation that could result in terminal patients receiving therapies still to be approved by the Food and Drug Administration, The Wall Street Journal reported.

The bill, which received unanimous legislative support and was signed by Colorado Gov. John Hickenlooper, does not force drug companies to give test drugs to potential patients outside those taking part in clinical trials.

However, right-to-try supporters hope that the act will lead to faster approval of life-saving drugs that often take years to be approved.

Arizona is due to vote on a right-to-try referendum this fall, while similar bills have been passed by state legislatures in Missouri and Louisiana but are still waiting for the governors to sign off on them, the Journal said.

The Goldwater Institute, a Phoenix-based conservative nonprofit advocacy group that put forward the proposals in these states, says it’s planning to push the measures in legislatures nationwide.

Colorado’s right-to-try act allows terminal patients to take experimental drugs that have cleared early-stage safety trials. The manufacturer must agree to provide them to the patients, while the FDA is no longer required to approve them in that state, as it has in the past.

State Sen. Irene Aguilar, a Denver Democrat and physician who co-sponsored the bill, said, "If a person has been diagnosed with something terminal, and they don't have any hope, and there is something out there they want to try that might work for them, I am supportive of people being able to do that."

The right-to-tryers are hoping their efforts will result in easier access to the new so-called cancer immunotherapies, which unleash the body’s immune system to fight tumors. They shrink tumors and have performed well in early clinical trials.

But the trade group Pharmaceutical Research and Manufacturers of America, warned that the public’s safety is not best served by circumventing FDA oversight, the Journal reports.

Sascha Haverfield, vice president of scientific and regulatory affairs at PhRMA, told the Journal, "Successful completion of the clinical trial process is necessary to demonstrate that an investigational medicine is safe and effective, which is required to obtain FDA approval, so that companies may make the medicine available to a broader patient population when clinically appropriate."

An FDA spokesman says the right-to-try movement is "inconsistent with its congressionally mandated authority and agency mission to protect the public from therapies that aren't safe and effective."

Related Stories:




© 2014 Newsmax. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Texas Calls Voter ID Trial Obama Play For Minority Votes

Tuesday, 02 Sep 2014 15:34 PM

The U.S. Justice Department wants Texas back.
A trial that began today in Corpus Christi over the legality of a vot . . .

Apple Says ICloud Not Breached in Celebrity Photo Hack

Tuesday, 02 Sep 2014 15:22 PM

Apple said Tuesday that certain accounts of Hollywood celebrities were compromised via a very targeted attack on its s . . .

Americans Still Use Libraries, But Question Long-Term Relevancy

Tuesday, 02 Sep 2014 15:09 PM

Despite having used a public library in the last year, most Americans do not believe they will remain relevant in the ag . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved